Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DK6U4E
|
|||
| Drug Name |
ZMapp
|
|||
| Indication | Ebola virus infection [ICD-11: 1D60.0] | Phase 2/3 | [1] | |
| Company |
Mapp Biopharmaceutical San Diego, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03719586) Investigational Therapeutics for the Treatment of People With Ebola Virus Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.